Request Clinical Starter Kits for Your Patients Today! Request Now


Berberine promotes weight loss, meta-analysis shows

Highlights Meta-analysis of 12 clinical trials Berberine significantly reduces body weight, BMI, waist circumference, and CRP levels Typical dosage is 1,000-1,500 mg/day for 3 months No adverse effect on liver...
on April 10, 2024

Berberine for type 2 diabetes: meta-analysis and dosage recommendation

Highlights Meta-analysis of 46 clinical trials involving people with type 2 diabetes Berberine significantly improves glycemic control, blood lipid profile, inflammation, and BMI Typical dosage is 300-500 mg, three times daily,...
on April 03, 2024

Berberine is a potent hypoglycemic agent, comparable to metformin, study shows

Highlights Berberine is as effective as metformin for glycemic control in adults with newly diagnosed type 2 diabetes. Berberine added to usual hypoglycemic therapy improves glycemic control in adults with...
on February 28, 2024

Resveratrol improves endothelial function in patients with kidney disease and diabetes, study shows

Highlights Randomized, double-blind, placebo-controlled, cross-over trial involving 21 older adults with stage 3 CKD and diabetes Supplementation consist of ResVida 99% pure, all-trans resveratrol supplementation (200 mg/day, twice daily) for 6 weeks (treatment and matching...
on February 07, 2024

Compared to oral berberine, oral dihydroberberine achieves a higher blood berberine level with lower doses, study shows

Highlights Berberine supplementation has therapeutic value for glycemic control, but digestive upset and poor patient compliance is common. Compared to high-dose berberine (500 mg), low-dose dihydroberberine (100 or 200 mg) significantly (p<.05)...
on January 23, 2024